カテゴリー： GlobalInfoResearch, 世界, 部品/材料

世界の生体模倣ペプチド市場2022年：レジュリン、ブーストリン、CG-EGP3、CG-TGP2、その他

◆英語タイトル：Global Biomimetic Peptide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY0701）◆商品コード：GIR22MY0701
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：93
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

生体模倣ペプチド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の生体模倣ペプチドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

生体模倣ペプチド市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・レジュリン、ブーストリン、CG-EGP3、CG-TGP2、その他

用途別セグメントは次のように区分されます。
・化粧品、医薬品、その他

世界の生体模倣ペプチド市場の主要な市場プレーヤーは以下のとおりです。
・Lucas Meyer、Koninklijke、DSM、Caregen、Swedish Biomimetics 3000、Pharmann

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、生体模倣ペプチド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な生体模倣ペプチドメーカーの企業概要、2019年～2022年までの生体模倣ペプチドの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な生体模倣ペプチドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別生体模倣ペプチドの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの生体模倣ペプチドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での生体模倣ペプチド市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および生体模倣ペプチドの産業チェーンを掲載しています。
・第13、14、15章では、生体模倣ペプチドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Lucas Meyer、Koninklijke、DSM、Caregen、Swedish Biomimetics 3000、Pharmann
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：レジュリン、ブーストリン、CG-EGP3、CG-TGP2、その他
・用途別分析2017年-2028年：化粧品、医薬品、その他
・生体模倣ペプチドの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・生体模倣ペプチドのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・生体模倣ペプチドのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・生体模倣ペプチドの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・生体模倣ペプチドの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Biomimetic Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biomimetic Peptide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Cosmetics accounting for % of the Biomimetic Peptide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Rejuline segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biomimetic Peptide include Lucas Meyer, Koninklijke, DSM, Caregen, and Swedish Biomimetics 3000, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biomimetic Peptide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rejuline
Boostrin
CG-EGP3
CG-TGP2
Others
Market segment by Application can be divided into
Cosmetics
Pharmaceuticals
Others
The key market players for global Biomimetic Peptide market are listed below:
Lucas Meyer
Koninklijke
DSM
Caregen
Swedish Biomimetics 3000
Pharmann
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biomimetic Peptide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biomimetic Peptide, with price, sales, revenue and global market share of Biomimetic Peptide from 2019 to 2022.
Chapter 3, the Biomimetic Peptide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biomimetic Peptide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biomimetic Peptide market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biomimetic Peptide.
Chapter 13, 14, and 15, to describe Biomimetic Peptide sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Biomimetic Peptide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biomimetic Peptide Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Rejuline
1.2.3 Boostrin
1.2.4 CG-EGP3
1.2.5 CG-TGP2
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biomimetic Peptide Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cosmetics
1.3.3 Pharmaceuticals
1.3.4 Others
1.4 Global Biomimetic Peptide Market Size & Forecast
1.4.1 Global Biomimetic Peptide Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biomimetic Peptide Sales in Volume (2017-2028)
1.4.3 Global Biomimetic Peptide Price (2017-2028)
1.5 Global Biomimetic Peptide Production Capacity Analysis
1.5.1 Global Biomimetic Peptide Total Production Capacity (2017-2028)
1.5.2 Global Biomimetic Peptide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biomimetic Peptide Market Drivers
1.6.2 Biomimetic Peptide Market Restraints
1.6.3 Biomimetic Peptide Trends Analysis
2 Manufacturers Profiles
2.1 Lucas Meyer
2.1.1 Lucas Meyer Details
2.1.2 Lucas Meyer Major Business
2.1.3 Lucas Meyer Biomimetic Peptide Product and Services
2.1.4 Lucas Meyer Biomimetic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Koninklijke
2.2.1 Koninklijke Details
2.2.2 Koninklijke Major Business
2.2.3 Koninklijke Biomimetic Peptide Product and Services
2.2.4 Koninklijke Biomimetic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 DSM
2.3.1 DSM Details
2.3.2 DSM Major Business
2.3.3 DSM Biomimetic Peptide Product and Services
2.3.4 DSM Biomimetic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Caregen
2.4.1 Caregen Details
2.4.2 Caregen Major Business
2.4.3 Caregen Biomimetic Peptide Product and Services
2.4.4 Caregen Biomimetic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Swedish Biomimetics 3000
2.5.1 Swedish Biomimetics 3000 Details
2.5.2 Swedish Biomimetics 3000 Major Business
2.5.3 Swedish Biomimetics 3000 Biomimetic Peptide Product and Services
2.5.4 Swedish Biomimetics 3000 Biomimetic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pharmann
2.6.1 Pharmann Details
2.6.2 Pharmann Major Business
2.6.3 Pharmann Biomimetic Peptide Product and Services
2.6.4 Pharmann Biomimetic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biomimetic Peptide Breakdown Data by Manufacturer
3.1 Global Biomimetic Peptide Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biomimetic Peptide Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biomimetic Peptide
3.4 Market Concentration Rate
3.4.1 Top 3 Biomimetic Peptide Manufacturer Market Share in 2021
3.4.2 Top 6 Biomimetic Peptide Manufacturer Market Share in 2021
3.5 Global Biomimetic Peptide Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biomimetic Peptide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biomimetic Peptide Market Size by Region
4.1.1 Global Biomimetic Peptide Sales in Volume by Region (2017-2028)
4.1.2 Global Biomimetic Peptide Revenue by Region (2017-2028)
4.2 North America Biomimetic Peptide Revenue (2017-2028)
4.3 Europe Biomimetic Peptide Revenue (2017-2028)
4.4 Asia-Pacific Biomimetic Peptide Revenue (2017-2028)
4.5 South America Biomimetic Peptide Revenue (2017-2028)
4.6 Middle East and Africa Biomimetic Peptide Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Biomimetic Peptide Sales in Volume by Type (2017-2028)
5.2 Global Biomimetic Peptide Revenue by Type (2017-2028)
5.3 Global Biomimetic Peptide Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Biomimetic Peptide Sales in Volume by Application (2017-2028)
6.2 Global Biomimetic Peptide Revenue by Application (2017-2028)
6.3 Global Biomimetic Peptide Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Biomimetic Peptide Sales by Type (2017-2028)
7.2 North America Biomimetic Peptide Sales by Application (2017-2028)
7.3 North America Biomimetic Peptide Market Size by Country
7.3.1 North America Biomimetic Peptide Sales in Volume by Country (2017-2028)
7.3.2 North America Biomimetic Peptide Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Biomimetic Peptide Sales by Type (2017-2028)
8.2 Europe Biomimetic Peptide Sales by Application (2017-2028)
8.3 Europe Biomimetic Peptide Market Size by Country
8.3.1 Europe Biomimetic Peptide Sales in Volume by Country (2017-2028)
8.3.2 Europe Biomimetic Peptide Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biomimetic Peptide Sales by Type (2017-2028)
9.2 Asia-Pacific Biomimetic Peptide Sales by Application (2017-2028)
9.3 Asia-Pacific Biomimetic Peptide Market Size by Region
9.3.1 Asia-Pacific Biomimetic Peptide Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biomimetic Peptide Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Biomimetic Peptide Sales by Type (2017-2028)
10.2 South America Biomimetic Peptide Sales by Application (2017-2028)
10.3 South America Biomimetic Peptide Market Size by Country
10.3.1 South America Biomimetic Peptide Sales in Volume by Country (2017-2028)
10.3.2 South America Biomimetic Peptide Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biomimetic Peptide Sales by Type (2017-2028)
11.2 Middle East & Africa Biomimetic Peptide Sales by Application (2017-2028)
11.3 Middle East & Africa Biomimetic Peptide Market Size by Country
11.3.1 Middle East & Africa Biomimetic Peptide Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biomimetic Peptide Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Biomimetic Peptide and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biomimetic Peptide
12.3 Biomimetic Peptide Production Process
12.4 Biomimetic Peptide Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biomimetic Peptide Typical Distributors
13.3 Biomimetic Peptide Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Biomimetic Peptide Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biomimetic Peptide Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Lucas Meyer Basic Information, Manufacturing Base and Competitors
Table 4. Lucas Meyer Major Business
Table 5. Lucas Meyer Biomimetic Peptide Product and Services
Table 6. Lucas Meyer Biomimetic Peptide Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Koninklijke Basic Information, Manufacturing Base and Competitors
Table 8. Koninklijke Major Business
Table 9. Koninklijke Biomimetic Peptide Product and Services
Table 10. Koninklijke Biomimetic Peptide Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. DSM Basic Information, Manufacturing Base and Competitors
Table 12. DSM Major Business
Table 13. DSM Biomimetic Peptide Product and Services
Table 14. DSM Biomimetic Peptide Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Caregen Basic Information, Manufacturing Base and Competitors
Table 16. Caregen Major Business
Table 17. Caregen Biomimetic Peptide Product and Services
Table 18. Caregen Biomimetic Peptide Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Swedish Biomimetics 3000 Basic Information, Manufacturing Base and Competitors
Table 20. Swedish Biomimetics 3000 Major Business
Table 21. Swedish Biomimetics 3000 Biomimetic Peptide Product and Services
Table 22. Swedish Biomimetics 3000 Biomimetic Peptide Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pharmann Basic Information, Manufacturing Base and Competitors
Table 24. Pharmann Major Business
Table 25. Pharmann Biomimetic Peptide Product and Services
Table 26. Pharmann Biomimetic Peptide Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Biomimetic Peptide Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 28. Global Biomimetic Peptide Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Biomimetic Peptide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Biomimetic Peptide Production Capacity by Company, (Kg): 2020 VS 2021
Table 31. Head Office and Biomimetic Peptide Production Site of Key Manufacturer
Table 32. Biomimetic Peptide New Entrant and Capacity Expansion Plans
Table 33. Biomimetic Peptide Mergers & Acquisitions in the Past Five Years
Table 34. Global Biomimetic Peptide Sales by Region (2017-2022) & (Kg)
Table 35. Global Biomimetic Peptide Sales by Region (2023-2028) & (Kg)
Table 36. Global Biomimetic Peptide Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Biomimetic Peptide Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 39. Global Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 40. Global Biomimetic Peptide Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Biomimetic Peptide Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Biomimetic Peptide Price by Type (2017-2022) & (US$/Kg)
Table 43. Global Biomimetic Peptide Price by Type (2023-2028) & (US$/Kg)
Table 44. Global Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 45. Global Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 46. Global Biomimetic Peptide Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Biomimetic Peptide Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Biomimetic Peptide Price by Application (2017-2022) & (US$/Kg)
Table 49. Global Biomimetic Peptide Price by Application (2023-2028) & (US$/Kg)
Table 50. North America Biomimetic Peptide Sales by Country (2017-2022) & (Kg)
Table 51. North America Biomimetic Peptide Sales by Country (2023-2028) & (Kg)
Table 52. North America Biomimetic Peptide Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Biomimetic Peptide Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 55. North America Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 56. North America Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 57. North America Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 58. Europe Biomimetic Peptide Sales by Country (2017-2022) & (Kg)
Table 59. Europe Biomimetic Peptide Sales by Country (2023-2028) & (Kg)
Table 60. Europe Biomimetic Peptide Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Biomimetic Peptide Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 63. Europe Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 64. Europe Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 65. Europe Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 66. Asia-Pacific Biomimetic Peptide Sales by Region (2017-2022) & (Kg)
Table 67. Asia-Pacific Biomimetic Peptide Sales by Region (2023-2028) & (Kg)
Table 68. Asia-Pacific Biomimetic Peptide Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Biomimetic Peptide Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 71. Asia-Pacific Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 72. Asia-Pacific Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 73. Asia-Pacific Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 74. South America Biomimetic Peptide Sales by Country (2017-2022) & (Kg)
Table 75. South America Biomimetic Peptide Sales by Country (2023-2028) & (Kg)
Table 76. South America Biomimetic Peptide Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Biomimetic Peptide Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 79. South America Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 80. South America Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 81. South America Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 82. Middle East & Africa Biomimetic Peptide Sales by Region (2017-2022) & (Kg)
Table 83. Middle East & Africa Biomimetic Peptide Sales by Region (2023-2028) & (Kg)
Table 84. Middle East & Africa Biomimetic Peptide Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Biomimetic Peptide Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Biomimetic Peptide Sales by Type (2017-2022) & (Kg)
Table 87. Middle East & Africa Biomimetic Peptide Sales by Type (2023-2028) & (Kg)
Table 88. Middle East & Africa Biomimetic Peptide Sales by Application (2017-2022) & (Kg)
Table 89. Middle East & Africa Biomimetic Peptide Sales by Application (2023-2028) & (Kg)
Table 90. Biomimetic Peptide Raw Material
Table 91. Key Manufacturers of Biomimetic Peptide Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Biomimetic Peptide Typical Distributors
Table 95. Biomimetic Peptide Typical Customers
List of Figures
Figure 1. Biomimetic Peptide Picture
Figure 2. Global Biomimetic Peptide Revenue Market Share by Type in 2021
Figure 3. Rejuline
Figure 4. Boostrin
Figure 5. CG-EGP3
Figure 6. CG-TGP2
Figure 7. Others
Figure 8. Global Biomimetic Peptide Revenue Market Share by Application in 2021
Figure 9. Cosmetics
Figure 10. Pharmaceuticals
Figure 11. Others
Figure 12. Global Biomimetic Peptide Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 13. Global Biomimetic Peptide Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Biomimetic Peptide Sales (2017-2028) & (Kg)
Figure 15. Global Biomimetic Peptide Price (2017-2028) & (US$/Kg)
Figure 16. Global Biomimetic Peptide Production Capacity (2017-2028) & (Kg)
Figure 17. Global Biomimetic Peptide Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Biomimetic Peptide Market Drivers
Figure 19. Biomimetic Peptide Market Restraints
Figure 20. Biomimetic Peptide Market Trends
Figure 21. Global Biomimetic Peptide Sales Market Share by Manufacturer in 2021
Figure 22. Global Biomimetic Peptide Revenue Market Share by Manufacturer in 2021
Figure 23. Biomimetic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Biomimetic Peptide Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Biomimetic Peptide Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Biomimetic Peptide Sales Market Share by Region (2017-2028)
Figure 27. Global Biomimetic Peptide Revenue Market Share by Region (2017-2028)
Figure 28. North America Biomimetic Peptide Revenue (2017-2028) & (USD Million)
Figure 29. Europe Biomimetic Peptide Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Biomimetic Peptide Revenue (2017-2028) & (USD Million)
Figure 31. South America Biomimetic Peptide Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Biomimetic Peptide Revenue (2017-2028) & (USD Million)
Figure 33. Global Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 34. Global Biomimetic Peptide Revenue Market Share by Type (2017-2028)
Figure 35. Global Biomimetic Peptide Price by Type (2017-2028) & (US$/Kg)
Figure 36. Global Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 37. Global Biomimetic Peptide Revenue Market Share by Application (2017-2028)
Figure 38. Global Biomimetic Peptide Price by Application (2017-2028) & (US$/Kg)
Figure 39. North America Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 40. North America Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 41. North America Biomimetic Peptide Sales Market Share by Country (2017-2028)
Figure 42. North America Biomimetic Peptide Revenue Market Share by Country (2017-2028)
Figure 43. United States Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 47. Europe Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 48. Europe Biomimetic Peptide Sales Market Share by Country (2017-2028)
Figure 49. Europe Biomimetic Peptide Revenue Market Share by Country (2017-2028)
Figure 50. Germany Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Biomimetic Peptide Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Biomimetic Peptide Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Biomimetic Peptide Revenue Market Share by Region (2017-2028)
Figure 59. China Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 66. South America Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 67. South America Biomimetic Peptide Sales Market Share by Country (2017-2028)
Figure 68. South America Biomimetic Peptide Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Biomimetic Peptide Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Biomimetic Peptide Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Biomimetic Peptide Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Biomimetic Peptide Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Biomimetic Peptide Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Biomimetic Peptide in 2021
Figure 80. Manufacturing Process Analysis of Biomimetic Peptide
Figure 81. Biomimetic Peptide Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の生体模倣ペプチド市場2022年：レジュリン、ブーストリン、CG-EGP3、CG-TGP2、その他(Global Biomimetic Peptide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 生体模倣レチノールのグローバル市場予測2023-2029
  • 世界の生体模倣ペプチド市場インサイト及び予測（Rejuline、Boostrin、CG-EGP3、CG-TGP2、その他）
  • 世界のシルクペプチド市場2022年：シルクペプチド粉末、シルクペプチド溶液
  • 世界の大豆ペプチド粉末市場2022年：内因性ペプチド粉末、合成ペプチド粉末、酵素ペプチド粉末
  • 世界のバイオミメティック防汚塗料市場2022年：物理バイオニック法、化学的バイオニック法